Client News

Abivax Announces Full Year 2024 Financial Result

Formycon Invites to Conference Call on the Results of the Financial Year 2024 and Announces Participation in International Investor Conferences in the 2nd Quarter of 2025

Heidelberg Pharma Announces Financial Figures and Reports on Successful Business Performance in 2024

Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy

InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones

Meliodays Medical Announces the Closing of a Pre-Seed Financing Round of over €800,000

Viromed Medical AG Reports Promising Study Results for PulmoPlas® in Intensive Care Unit Ventilator-Associated Pneumonia Patients

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty